Arjun Agarwal sold $1.1M of Oruka Therapeutics (ORKA)

Executed Aug 13, disclosed Aug 14, 1 day later.

Value, as filed

$1.1M

10,000 sh across 5 lots

Executed

Aug 13

the trade date, as filed

Disclosed

Aug 14

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Arjun Agarwal Senior Vice President, Finance profile →

Arjun Agarwal (Senior Vice President, Finance) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Oruka Therapeutics, Inc. (ORKA). The largest single filing was $1.1M of ORKA (10,000 sh across 5 lots, as filed), executed Aug 13.

The name

ORKA

Oruka Therapeutics, Inc. ORKA · Healthcare · 27 filings in 24 months ticker →

Healthcare · Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psor…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Arjun Agarwal in ORKA

ORKASALE Oruka Therapeutics, Inc. $854K
9,259 sh across 3 lots
Exec Sep 11
Filed Sep 15 · 7:17 PM ET ORKASALE Oruka Therapeutics, Inc. $796K
9,399 sh across 2 lots
Exec Jul 13
Filed Jul 13 · 5:09 PM ET ORKASALE Oruka Therapeutics, Inc. $660K
9,459 sh across 3 lots
Exec Jun 12
Filed Jun 15 · 5:30 PM ET ORKASALE Oruka Therapeutics, Inc. $517K
8,790 sh across 2 lots
Exec May 18
Filed May 18 · 5:30 PM ET